The 3D bioprinting market is rapidly moving beyond the theoretical realm of organ transplantation and firmly into the commercial reality of drug development. For decades, the pharmaceutical industry has relied on two-dimensional cell cultures and animal testing to gauge the safety and efficacy of new drugs. However, these traditional models often fail to accurately mimic complex human biology,...
Romaian 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Portuguese (Brazil)
Greek